Current progress of mesenchymal stem cell membrane-camouflaged nanoparticles for targeted therapy.

Biomed Pharmacother

Scientific Research Center, China-Japan Union Hospital, Jilin University, Changchun130033, China. Electronic address:

Published: May 2023

Nanodrug delivery systems have been widely used in disease treatment. However, weak drug targeting, easy to be cleared by the immune system, and low biocompatibility are great obstacles for drug delivery. As an important part of cell information transmission and behavior regulation, cell membrane can be used as drug coating material which represents a promising strategy and can overcome these limitations. Mesenchymal stem cell (MSC) membrane, as a new carrier, has the characteristics of active targeting and immune escape of MSC, and has broad application potential in tumor treatment, inflammatory disease, tissue regeneration and other fields. Here, we review recent progress on the use of MSC membrane-coated nanoparticles for therapy and drug delivery, aiming to provide guidance for the design and clinical application of membrane carrier in the future.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biopha.2023.114451DOI Listing

Publication Analysis

Top Keywords

mesenchymal stem
8
stem cell
8
drug delivery
8
membrane carrier
8
current progress
4
progress mesenchymal
4
cell
4
cell membrane-camouflaged
4
membrane-camouflaged nanoparticles
4
nanoparticles targeted
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!